(Q72999026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

G Lepage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Paradis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F Lacaille

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L Sénéchal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N Ronco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Champagne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Lenaerts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C C Roy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Rasquin-Weber

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

52-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

Correction of linoleic acid deficiency in cystic fibrosis

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Gallstone dissolution therapy. Current status and future prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effects of ursodeoxycholic acid treatment on essential fatty acid deficiency in patients with biliary atresia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effects of ursodeoxycholic acid on plasma lipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Relative underweight in cystic fibrosis and its prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Hepatic delta 9 and delta 6 desaturase activities during the recovery period following carbon tetrachloride poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Gamma-linolenic acid inhibits the development of the ethanol-induced fatty liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Dietary arachidonic acid reduces fatty liver, increases diet consumption and weight gain in ethanol-fed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Intestinal retinol esterification and serum retinol in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Role of capillary endothelium in the clearance of chylomicrons. A model for lipid transport from blood by lateral diffusion in cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Vitamin A: physiological and biochemical processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Blood and Liver Concentrations of Vitamins A and E in Children with Cystic Fibrosis of the Pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Vitamin A transport in human vitamin A toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Hepatic hypervitaminosis A: a familial observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

Transport and metabolism of vitamin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970310-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(97)70310-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9003851%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference